| Dr Kimberly Mcdonald, | |
|
601 Smithfield Ave, Pawtucket, RI 02860-1682 | |
| (401) 727-1866 | |
| Not Available |
| Full Name | Dr Kimberly Mcdonald |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 601 Smithfield Ave, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154924140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH05743 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Mcdonald, 20 Vigilant St, Cranston, RI 02920-5127 Ph: (401) 316-3181 | Dr Kimberly Mcdonald, 601 Smithfield Ave, Pawtucket, RI 02860-1682 Ph: (401) 727-1866 |
News Archive
T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).
Cancer Research UK scientists have discovered that a gene called POLQ is linked to an eight-fold risk of breast cancer returning. Developing drugs to block POLQ could increase survival and stop the cancer coming back, according to research published in OncoTarget.
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy, according to a study in the April issue of the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
› Verified 8 days ago
Caitlin Anne Bilodeau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Broad St, Pawtucket, RI 02860 Phone: 401-724-5912 | |
Claudia Valenzuela, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 385 Cottage St, Pawtucket, RI 02861 Phone: 401-727-4407 Fax: 401-728-9480 | |
Mrs. Cheryl A Stoukides, BSC, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Newport Ave, Pawtucket, RI 02861 Phone: 401-722-7600 Fax: 401-722-9738 | |
Claudia A Bradley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 East Ave, Pawtucket, RI 02860 Phone: 401-722-8704 | |
Dr. Michael Ronald Cipriano, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Power Rd, Pawtucket, RI 02860 Phone: 401-724-3274 | |
Casey O'halloran, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Broad St, Pawtucket, RI 02860 Phone: 401-724-6724 | |
Dr. Allison Marie Zuern, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 407 East Ave Ste 200, Pawtucket, RI 02860 Phone: 401-606-1649 |